Carole Elford

2021

• Nishio Ayre, W. et al. 2021. Alternative radiopacifiers for polymethyl methacrylate bone cements: Silane-treated anatase titanium dioxide and yttria-stabilised zirconium dioxide. Journal of Biomaterials Applications 35(10), pp. 1235-1252. (10.1177/0885328220983797)

2016

• Holt, C. A. et al. 2016. Biological changes in tibial subchondral bone following high tibial osteotomy. Osteoarthritis and Cartilage 24(S1), pp. S511-S511. (10.1016/j.joca.2016.01.935)

2015

• Ishtiaq, S. et al. 2015. The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells. Cytokine 71(2), pp. 154-160. (10.1016/j.cyto.2014.10.025)

2009

• Henney, N. C., Li, B., Elford, C., Reviriego, P., Campbell, A. K., Wann, K. T. and Evans, B. A. J. 2009. A large-conductance (BK) potassium channel subtype affects both growth and mineralization of human osteoblasts. American Journal of Physiology - Cell Physiology 297(6), pp. C1397-C1408. (10.1152/ajpcell.00311.2009)
• Williams, A. S. et al. 2009. A functional role for death receptor-3 in arthritis [Abstract]. Cytokine 48(1-2), pp. 134-134. (10.1016/j.cyto.2009.07.568)
• Williams, A. S. et al. 2009. Functional role of dr3 in inflammatory arthritis: A novel target for therapy? [Abstract]. Rheumatology 48(s1), pp. I8-I8. (10.1093/rheumatology/kep704)
• Stevenson, A. E. et al. 2009. Does adiposity status influence femoral cortical strength in rodent models of growth hormone deficiency?. American Journal of Physiology - Endocrinology and Metabolism 296(1), pp. E147-E156. (10.1152/ajpendo.90689.2008)

2008

• Williams, A. S. et al. 2008. The role of death receptor 3 in inflammatory arthritis [Abstract]. Immunology 125, pp. 34-34. (10.1111/j.1365-2567.2008.02974.x)
• Bull, M. J. et al. 2008. The Death Receptor 3-TNF-like protein 1A pathway drives adverse bone pathology in inflammatory arthritis. Journal of Experimental Medicine 205(11), pp. 2457-2464. (10.1084/jem.20072378)
• Janus, D., Evans, B. A. J., Elford, C., Scanlon, M. F. and Gregory, J. W. 2008. The effects of recombinant human growth hormone (GH) and insulin-like growth factor-I (IGF-I) on human osteoclasts [Abstract]. Hormone Research 70(S1), pp. 80-80. (10.1159/000157528)
• Janus, D., Evans, B. A. J., Elford, C., Scanlon, M. F. and Gregory, J. W. 2008. Age-dependent effects of growth hormone (GH) on human osteoclasts in growth hormone deficient patients [Abstract]. Hormone Research 70(S1), pp. 80-80. (10.1159/000157528)
• Gharibi, B., Elford, C., Lewis, B. M., Ham, J. and Evans, B. A. J. 2008. Evidence for adenosine receptor regulation of osteogenesis versus adipogenesis in mesenchymal stem cells [Abstract]. Calcified Tissue International 83(1), pp. 9-10. (10.1007/s00223-008-9151-4)
• Janus, D., Gregory, J. W., Elford, C., Scanlon, M. F. and Evans, B. A. J. 2008. The effects of recombinant human growth hormone (rhGh) and insulin-like growth FACTOR-I (rhIGF-I) on human osteoclasts [Abstract]. Calcified Tissue International 83(1), pp. 31-32. (10.1007/s00223-008-9151-4)

2007

• Mansergh, F. C., Wells, T., Elford, C., Evans, S. L., Evans, M. J., Perry, M. J. and Evans, B. A. J. 2007. Osteopenia in Sparc (osteonectin) deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression. Physiological genomics 32(1), pp. 64-73. (10.1152/physiolgenomics.00151.2007)
• Davies, J. S. et al. 2007. Adiposity profile in the dwarf (dw/dw) rat: an unusually lean model of profound growth hormone deficiency. American Journal of Physiology - Endocrinology and Metabolism 292(5), pp. E1483-E1494. (10.1152/ajpendo.00417.2006)

2006

• Evans, B. A. J., Elford, C., Pexa, A., Francis, K., Hughes, A., Deussen, A. and Ham, J. 2006. Human osteoblast precursors produce extracellular adenosine, which modulates their secretion of IL-6 and osteoprotegerin. Journal of Bone and Mineral Research 21(2), pp. 228-36. (10.1359/JBMR.051021)

2005

• Yee, S. W. et al. 2005. Novel tetralone-derived retinoic acid metabolism blocking agents: synthesis and in vitro evaluation with liver microsomal and MCF-7 CYP26A1 cell assays. Journal of Medicinal Chemistry 48(23), pp. 7123-7131. (10.1021/jm0501681)

2003

• Evans, B. A. J. et al. 2003. Morphological determinants of femoral strength in growth hormone-deficient transgenic growth-retarded (Tgr) rats. Journal of Bone and Mineral Research 18(7), pp. 1308-1316. (10.1359/jbmr.2003.18.7.1308)

2002

• Perez, N. A., Elford, C., Gregory, J. W. and Evans, B. A. J. 2002. Effects of leptin on number and apoptosis of osteoblasts, and control of leptin production by glucocorticoids. Journal of Bone and Mineral Research 17(7), pp. 1327-1327.
• Davies, J. H., Elford, C., Perez, N., Jenney, M., Gregory, J. W. and Evans, B. A. J. 2002. Chemotherapy-induced apoptosis in human osteoblast-like cells and modulation of their effects by dexamethasone. Journal of Bone and Mineral Research 17(7), pp. 1342-1342.
• Evans, B. A. J., Laib, A., Warner, J., Elford, C., Evans, S. L., Gregory, J. W. and Wells, T. 2002. 3D micro-computed tomography (micro-CT) of trabecular bone from growth hormone deficient transgenic rats. Journal of Bone and Mineral Research 17(7), pp. 1332-1332.

2000

• Warner, J. T., Wells, T., Elford, C., Evans, B. A. J., Evans, S. L. and Gregory, J. W. 2000. Undermineralisation and reduced bone strength in growth hormone (GH) deficient transgenic (Tgr) rats. Journal of Bone and Mineral Research (JBMR) 15(6), pp. 1219-1219.